Aridis Pharmaceuticals Inc
NASDAQ:ARDS
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ARDS's stock price target?
Not Available
ARDS doesn't have any price targets made by Wall Street professionals.
What is Aridis Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
193%
For the last 6 years the compound annual growth rate for Aridis Pharmaceuticals Inc's revenue is 5%. The projected CAGR for the next 3 years is 193%.